Vyndaqel®

PRINCIPAL DISPLAY PANEL - 20 mg Blister Pack Carton

Vyndaqel® 20 mg

tafamidis meglumina

Pfizer

Vyndaqel® 20 mg

tafamidis meglumina
Pfizer

VYNDAQEL
tafamidis meglumine capsule

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
TAFAMIDIS MEGLUMINE (UNII: ZU7CF08A1A) (TAFAMIDIS - UNII:8FG9H9D31J)	TAFAMIDIS MEGLUMINE	20 mg

Ingredient Name	Strength
Inactive Ingredients
GELATIN, UNSPECIFIED (UNII: 2G86QN327L)
GLYCERIN (UNII: PDC6A3C0OX)
SORBITOL (UNII: 506T60A25R)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
WATER (UNII: 059QF0KO0R)
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)
SORBITAN MONOOLEATE (UNII: 06XEA2VD56)
POLYSORBATE 80 (UNII: 6OZP39ZG8H)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:0069-8729-55	1 in 1 CARTON	01/17/2013	01/17/2013
1		30 in 1 BLISTER PACK; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
EXPORT ONLY		01/17/2013	01/17/2013

Labeler - Pfizer Laboratories Div Pfizer Inc (134489525)

Name	Address	ID/FEI	Business Operations
Establishment
DELMAR CHEMICALS INC		245906755	API MANUFACTURE(0069-8729)

Name	Address	ID/FEI	Business Operations
Establishment
Catalent Pharma Solutions, LLC		051762268	ANALYSIS(0069-8729) , MANUFACTURE(0069-8729)

Name	Address	ID/FEI	Business Operations
Establishment
AndersonBrecon Inc.		053217022	PACK(0069-8729) , LABEL(0069-8729)

Name	Address	ID/FEI	Business Operations
Establishment
Catalent Micron Technologies, Inc.		015966157	PARTICLE SIZE REDUCTION(0069-8729)

Revised: 10/2021

Document Id: 4eaa061b-7626-430b-b2b8-954d3b2fd415

Set id: 417238d2-98dd-47b4-95c5-5c06dc3702dc

Version: 4

Effective Time: 20211029

Pfizer Laboratories Div Pfizer Inc